Before Direct-Acting Antivirals for Hepatitis C Virus: Evaluation of Core Protein R70Q and L/C91M Substitutions in Chronically Infected Brazilian Patients Unresponsive to IFN and/or RBV
Viruses · 2023
DOI: 10.3390/v15010187 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Letícia Bomfim Campos und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Virology, Oswaldo Cruz Institute/Fiocruz, Rio de Janeiro 21040-900, Brazil. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Hepatitis C, Hepatitis C, Chronic, Liver Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), FAPERJ (Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro).
Abstract (Originalsprache)
Although chronic hepatitis C has been effectively treated with direct-acting antivirals (DAAs), the use of conventional therapy with peg-interferon (Peg-IFN) or (predominantly) ribavirin (RBV), remains widespread. R70Q/H and L/C91M amino acid substitutions in the hepatitis C virus (HCV) core protein may modulate responses to IFN and/or RBV, and are associated with cirrhosis, hepatocellular carcinoma (HCC), insulin resistance, and liver steatosis. We evaluated the R70Q/H and L/C91M substitutions, clinical and epidemiological profiles, and risk factors of Brazilian patients chronically infected with HCV subgenotypes 1a and 1b (HCV-GT1a and HCV-GT1b) unresponsive to IFN and/or RBV therapy. Sequencing and pyrosequencing analyses and sociodemographic and clinical predictive variables were used to assess the relationship between R70Q/H and L/C91M substitutions. Leukocyte counts, ALT levels, and ALT/AST ratios were significantly reduced in treated individuals, but more of these patients had advanced fibrosis and cirrhosis. L91M was more prevalent (19.7%), occurring only in HCV-GT1b, followed by R70Q/P (11.5%) and R70P (1.4%). R70Q/P exhibited higher mean AST, ALT, and GGT values, whereas L91M showed higher mean GGT values. Pyrosequencing of the L91M position revealed mutant subpopulations in 43.75% of samples.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Virology, Oswaldo Cruz Institute/Fiocruz, Rio de Janeiro 21040-900, Brazil.
- Gaffrée and Guinle University Hospital, Ambulatory of Liver Disease, Rio de Janeiro State Federal University/UniRio, Rio de Janeiro 20270-004, Brazil.
- BSL-3 Facility, Oswaldo Cruz Institute/Fiocruz, Rio de Janeiro 21040-900, Brazil.
ORCID-Profile: Vanessa Salete de Paula, José Júnior França de Barros
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- FAPERJ (Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro)
Zitieren
APA
Campos, L. B., de Almeida, N. A. A., de Santana, C. G., Barbosa, E. N. P., Horta, M. A. P., Amendola Pires, M., Brandão Mello, C. E., de Paula, V. S., & de Barros, J. J. F. (2023). Before Direct-Acting Antivirals for Hepatitis C Virus: Evaluation of Core Protein R70Q and L/C91M Substitutions in Chronically Infected Brazilian Patients Unresponsive to IFN and/or RBV. Viruses. https://doi.org/10.3390/v15010187
Vancouver
Campos LB, de Almeida NAA, de Santana CG, Barbosa ENP, Horta MAP, Amendola Pires M, et al. Before Direct-Acting Antivirals for Hepatitis C Virus: Evaluation of Core Protein R70Q and L/C91M Substitutions in Chronically Infected Brazilian Patients Unresponsive to IFN and/or RBV. Viruses. 2023. doi:10.3390/v15010187
BibTeX
@article{Campos2023,
author = {Campos, Letícia Bomfim and de Almeida, Nathália Alves Araújo and de Santana, Catarina Góis and Barbosa, Evorah Nascimento Pereira and Horta, Marco Aurelio Pereira and Amendola Pires, Márcia and Brandão Mello, Carlos Eduardo and de Paula, Vanessa Salete and de Barros, José Júnior França},
title = {Before Direct-Acting Antivirals for Hepatitis C Virus: Evaluation of Core Protein R70Q and L/C91M Substitutions in Chronically Infected Brazilian Patients Unresponsive to IFN and/or RBV},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15010187}
}
EUVIMED